Back to Search
MARK VELLEK, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1063409688IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
C2194(KY)20944(NV)R5H89(MO)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
UNIVERSITY OF MINNESOTA MEDICAL SCHOOL
Class of 1986
Research & Publications (2)
Results of a Phase II study of weekly docetaxel and carboplatin in Stage IIIB (with effusion) or Stage IV non-small cell lung cancer patients age<or=65 and performance status 2.
PMID 16621129·Lung Cancer·2006
3-trial
Results of a phase II multicenter trial of single-agent gemcitabine in patients with relapsed or chemotherapy-refractory Hodgkin's lymphoma.
PMID 15453926·Clin Lymphoma·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 1705 E BROADWAY, SUITE 100
COLUMBIA, MO 65201 - Phone
- (573) 874-7800
Quick Facts
- NPI
- 1063409688
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 3
- Years in Practice
- 40
- Publications
- 2
Are you this provider?
Claim Your Profile